Literature DB >> 31261087

Primary Immunodeficiency in the NICU.

Amy E O'Connell1.   

Abstract

Primary immunodeficiency disorders (PIDs) are genetic diseases that lead to increased susceptibility to infection. Hundreds of PIDs have now been described, but a select subset commonly presents in the neonatal period. Neonates, especially premature newborns, have relative immune immaturity that makes it challenging to differentiate PIDs from intrinsic immaturity. Nonetheless, early identification and appropriate management of PIDs are critical, and the neonatal clinician should be familiar with a range of PIDs and their presentations. The neonatal clinician should also be aware of the importance of consulting with an immunologist when a PID is suspected. The role of newborn screening for severe combined immunodeficiency, as well as the initial steps of laboratory evaluation for a PID should be familiar to those caring for neonates. Finally, it is important for providers to be familiar with the initial management steps that can be taken to reduce the risk of infection in affected patients.
Copyright © 2019 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2019        PMID: 31261087     DOI: 10.1542/neo.20-2-e67

Source DB:  PubMed          Journal:  Neoreviews        ISSN: 1526-9906


  3 in total

1.  Premature Infants Have Normal Maturation of the T Cell Receptor Repertoire at Term.

Authors:  Sarah U Morton; Maureen Schnur; Rylee Kerper; Vanessa Young; Amy E O'Connell
Journal:  Front Immunol       Date:  2022-05-30       Impact factor: 8.786

Review 2.  Inborn Errors of Immunity in the Premature Infant: Challenges in Recognition and Diagnosis.

Authors:  Scott M Gordon; Amy E O'Connell
Journal:  Front Immunol       Date:  2021-12-24       Impact factor: 8.786

Review 3.  Newborn Screening for Primary Immunodeficiencies: The Gaps, Challenges, and Outlook for Developing Countries.

Authors:  Zeinab A El-Sayed; Nesrine Radwan
Journal:  Front Immunol       Date:  2020-01-30       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.